NYSE:AGL

Agilon Health (AGL) Stock Price, News & Analysis

Agilon Health logo
$112.79 +8.12 (+7.76%)
Closing price 03:59 PM Eastern
Extended Trading
$113.87 +1.08 (+0.96%)
As of 07:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Agilon Health Stock (NYSE:AGL)

Advanced

Key Stats

Today's Range
$102.32
$114.41
50-Day Range
$16.60
$115.38
52-Week Range
$7.48
$118.25
Volume
417,101 shs
Average Volume
353,611 shs
Market Capitalization
$1.88 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$58.73
Consensus Rating
Hold

Company Overview

Agilon Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
28th Percentile Overall Score

AGL MarketRank™: 

Agilon Health scored higher than 28% of companies evaluated by MarketBeat, and ranked 732nd out of 852 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Agilon Health has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on no strong buy ratings, 5 buy ratings, 8 hold ratings, and 2 sell ratings.

  • Downside Risk

    Agilon Health has a consensus price target of $58.73, representing about 47.9% downside from its current price of $112.79.

  • Amount of Analyst Coverage

    Agilon Health has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Agilon Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Agilon Health are expected to grow in the coming year, from ($3.50) to ($3.12) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Agilon Health is -5.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Agilon Health is -5.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Agilon Health has a P/B Ratio of 14.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Agilon Health's valuation and earnings.
  • Percentage of Shares Shorted

    3.88% of the float of Agilon Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Agilon Health has a short interest ratio ("days to cover") of 2.06, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Agilon Health has recently decreased by 1.18%, indicating that investor sentiment is improving.
  • Dividend Yield

    Agilon Health does not currently pay a dividend.

  • Dividend Growth

    Agilon Health does not have a long track record of dividend growth.

  • Search Interest

    9 people have searched for AGL on MarketBeat in the last 30 days. This is an increase of 13% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Agilon Health to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Agilon Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.30% of the stock of Agilon Health is held by insiders.

  • Percentage Held by Institutions

    Agilon Health has minimal institutional ownership at this time.

  • Read more about Agilon Health's insider trading history.
Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilon Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AGL Stock News Headlines

agilon health to Participate in Upcoming Conferences
A huge SpaceX error just led one stock to 3X move!
SPCE surged roughly 300% in a single week after investors hunting SpaceX exposure piled into the wrong ticker. That window has closed - but the next opportunity may still be open. Trader Lance Ippolito has released a free SpaceX Investing Blackbook covering pre-IPO positioning plays, the space stock Goldman Sachs, BlackRock, and Morgan Stanley are loading up on, and the chip supplier Starlink satellites depend on.tc pixel
Agilon Health Announces 1-for-25 Reverse Stock Split
Barclays upgrades Agilon Health (AGL)
See More Headlines

AGL Stock Analysis - Frequently Asked Questions

Agilon Health's stock was trading at $17.2125 on January 1st, 2026. Since then, AGL shares have increased by 555.3% and is now trading at $112.7880.

Agilon Health, Inc. (NYSE:AGL) released its quarterly earnings data on Wednesday, May, 6th. The company reported $1.80 EPS for the quarter, topping the consensus estimate of $1.04 by $0.76. The business had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.38 billion. Agilon Health had a negative trailing twelve-month return on equity of 146.03% and a negative net margin of 6.09%.
Read the conference call transcript
.

Agilon Health shares reverse split on Tuesday, March 31st 2026.The 1-25 reverse split was announced on Wednesday, March 18th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Monday, March 30th 2026. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Agilon Health (AGL) raised $1 billion in an initial public offering (IPO) on Thursday, April 15th 2021. The company issued 46,600,000 shares at $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities served as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Agilon Health investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
5/06/2026
Today
6/18/2026
Next Earnings (Estimated)
8/03/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NYSE:AGL
CIK
1831097
Fax
N/A
Employees
1,076
Year Founded
2016

Price Target and Rating

High Price Target
$95.00
Low Price Target
$21.00
Potential Upside/Downside
-47.9%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
15 Analysts

Profitability

EPS (Trailing Twelve Months)
($21.56)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$391.35 million
Net Margins
-6.09%
Pretax Margin
-6.40%
Return on Equity
-146.03%
Return on Assets
-24.55%

Debt

Debt-to-Equity Ratio
0.08
Current Ratio
1.04
Quick Ratio
1.04

Sales & Book Value

Annual Sales
$5.93 billion
Price / Sales
0.32
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.64 per share
Price / Book
14.76

Miscellaneous

Outstanding Shares
16,680,000
Free Float
16,300,000
Market Cap
$1.88 billion
Optionable
Not Optionable
Beta
3.02

Social Links

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:AGL) was last updated on 6/18/2026 by MarketBeat.com Staff.
From Our Partners